XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 8 $ 976,955 $ 919 $ (699,171) $ 278,711
Balance (in shares) at Dec. 31, 2019 78,005        
Issuance of common stock upon exercise of stock options   10,808     10,808
Issuance of common stock upon exercise of stock options (in shares) 1,037        
Issuance of common stock under employee stock purchase plan   3,062     3,062
Issuance of common stock under employee stock purchase plan (in shares) 97        
Equity component of Convertible Notes, net   82,873     82,873
Vesting of restricted stock units (in shares) 578        
Stock based compensation   19,374     19,374
Unrealized (loss) gain on available-for-sale securities     4,851   4,851
Cumulative-effect adjustment upon adoption       (403) (403)
Net loss       (95,009) (95,009)
Balance at Jun. 30, 2020 $ 8 1,093,072 5,770 (794,583) 304,267
Balance (in shares) at Jun. 30, 2020 79,717        
Balance at Mar. 31, 2020 $ 8 988,199 5,666 (734,946) 258,927
Balance (in shares) at Mar. 31, 2020 78,652        
Issuance of common stock upon exercise of stock options   6,981     6,981
Issuance of common stock upon exercise of stock options (in shares) 680        
Issuance of common stock under employee stock purchase plan   3,062     3,062
Issuance of common stock under employee stock purchase plan (in shares) 97        
Equity component of Convertible Notes, net   82,873     82,873
Vesting of restricted stock units (in shares) 288        
Stock based compensation   11,957     11,957
Unrealized (loss) gain on available-for-sale securities     104   104
Net loss       (59,637) (59,637)
Balance at Jun. 30, 2020 $ 8 1,093,072 5,770 (794,583) 304,267
Balance (in shares) at Jun. 30, 2020 79,717        
Balance at Dec. 31, 2020 $ 9 1,411,286 4,259 (929,318) $ 486,236
Balance (in shares) at Dec. 31, 2020 86,223       86,223
Issuance of common stock upon exercise of stock options   6,829     $ 6,829
Issuance of common stock upon exercise of stock options (in shares) 782        
Issuance of common stock under employee stock purchase plan   6,085     6,085
Issuance of common stock under employee stock purchase plan (in shares) 106        
Vesting of restricted stock units (in shares) 1,387        
Stock based compensation   58,335     58,335
Unrealized (loss) gain on available-for-sale securities     (1,818)   (1,818)
Cumulative-effect adjustment upon adoption   (82,876)   6,198 (76,678)
Net loss       (179,879) (179,879)
Balance at Jun. 30, 2021 $ 9 1,399,659 2,441 (1,102,999) $ 299,110
Balance (in shares) at Jun. 30, 2021 88,498       88,498
Balance at Mar. 31, 2021 $ 9 1,356,212 3,197 (986,973) $ 372,445
Balance (in shares) at Mar. 31, 2021 87,430        
Issuance of common stock upon exercise of stock options   2,259     2,259
Issuance of common stock upon exercise of stock options (in shares) 207        
Issuance of common stock under employee stock purchase plan   6,085     6,085
Issuance of common stock under employee stock purchase plan (in shares) 106        
Vesting of restricted stock units (in shares) 755        
Stock based compensation   35,103     35,103
Unrealized (loss) gain on available-for-sale securities     (756)   (756)
Net loss       (116,026) (116,026)
Balance at Jun. 30, 2021 $ 9 $ 1,399,659 $ 2,441 $ (1,102,999) $ 299,110
Balance (in shares) at Jun. 30, 2021 88,498       88,498